Stem Cells and Cloning in the Public Eye

From golden rice to global warming, science makes headlines these days like never before. Not since Dolly the sheep made her debut five years ago did a scientific issue command as much attention as did cloning and stem cells during the week of Aug. 6. As soon as the White House announced on Thursday afternoon, Aug. 9, that President George W. Bush would make a nationally televised speech that evening regarding federal funding of stem cell research, newspapers, TV, and the Internet courted the s

Written byBarry Palevitz
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

As soon as the White House announced on Thursday afternoon, Aug. 9, that President George W. Bush would make a nationally televised speech that evening regarding federal funding of stem cell research, newspapers, TV, and the Internet courted the story, complete with voyeuristic views of eggs pricked with a new set of genetic instructions. Along with the latest news, we were also stuffed with the usual pontifications from preening pundits and science wonk wannabees. Nobody was sheepish about expressing opinions, no matter how "unseminal."

Bush's decision to narrowly support stem cell research also pushed a related event off page one. Gathered earlier in the week at the behest of the National Academy of Sciences in Washington, an army of physicians, researchers, and ethicists tackled the propriety and feasibility of human cloning for therapeutic and reproductive purposes.

With all the coverage, cloning and stem cells probably fertilized conversation over many a ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies